Funding for this research was provided by:
Received: 7 August 2020
Accepted: 23 December 2020
First Online: 6 January 2021
Change Date: 15 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S12882-021-02300-6
Ethics approval and consent to participate
: The research protocol was approved by the institutional review board at Hennepin Healthcare, and data use agreements between the Hennepin Healthcare Research Institute and the USRDS were in place. Need for consent was waived because data are de-identified.
: Not applicable.
: Dr. Roetker is Principal Investigator of research grants to Hennepin Healthcare Research Institute from Amgen. Yi Peng was Principal Investigator of research grants to Hennepin Healthcare Research Institute from Amgen. Dr. Wetmore is a consultant for Aurinia and Reata, and receives grant/research support through Hennepin Healthcare Research Institute from NIH (NIDDK), OPKO, Merck, Relypsa, Genentech, Bristol-Myers Squibb, and ACADIA. Dr. Decker-Palmer is an employee at Genentech, Inc. – a member of the Roche Group. Haifeng Guo declares no other relevant financial interests.